Skip to main content
Top
Published in: International Urology and Nephrology 6/2016

01-06-2016 | Urology - Original Paper

Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma

Authors: Bong Hee Park, Hyun Hwan Sung, Byong Chang Jeong, Seong II Seo, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, Hwang Gyun Jeon

Published in: International Urology and Nephrology | Issue 6/2016

Login to get access

Abstract

Purpose

To assess the association between tumor size and postoperative compensatory hypertrophy of the contralateral kidney estimated with preoperative and postoperative CT in patients with renal cell carcinoma (RCC).

Methods

We prospectively identified 728 patients who underwent radical nephrectomy for RCC between 2012 and 2014. Contrast-enhanced CT was done within 3 months preoperatively and 1 year postoperatively. A tissue segmentation tool program with CT images was used to estimate kidney volume. We divided patients into three groups according to tumor size (A: ≤4 cm, B: 4–7 cm, C: >7 cm). Preoperative and postoperative volumetric kidney parameters were compared and multivariable linear regression model was used to analyze predictors associated with postoperative compensatory hypertrophy.

Results

The preoperative median contralateral kidney volume was significantly larger in group C than in groups A and B (A: 170.3, B: 176.9, C: 186.8 mL, p < 0.05); the median tumor-side renal parenchymal volume was smaller in group C than in the other groups (A: 168.4, B: 171.1, C: 139.0 mL, p < 0.001). However, the postoperative median contralateral kidney volume among the three groups was not significantly different; the median contralateral kidney volume change after surgery was significantly larger in groups A and B than in group C (A: 37.8, B: 37.5, C: 27.4 mL, p < 0.05). Tumor size (≤7 cm) (p = 0.001) and male gender (p < 0.001) were significantly correlated with increased contralateral kidney volume on multivariable analysis. Tumor size showed the strongest positive association with postoperative contralateral kidney volume (A vs. C, partial regression coefficient = 10.6; B vs. C, partial regression coefficient = 10.5).

Conclusions

Tumor size (≤4 or 4–7 cm) and male gender are significant factors associated with compensatory hypertrophy after surgery.
Literature
3.
go back to reference Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913–924. doi:10.1016/j.eururo.2015.01.005 CrossRefPubMed Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913–924. doi:10.​1016/​j.​eururo.​2015.​01.​005 CrossRefPubMed
4.
go back to reference Pettus JA, Jang TL, Thompson RH, Yossepowitch O, Kagiwada M, Russo P (2008) Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors. Mayo Clin Proc 83:1101–1106. doi:10.4065/83.10.1101 CrossRefPubMedPubMedCentral Pettus JA, Jang TL, Thompson RH, Yossepowitch O, Kagiwada M, Russo P (2008) Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors. Mayo Clin Proc 83:1101–1106. doi:10.​4065/​83.​10.​1101 CrossRefPubMedPubMedCentral
6.
go back to reference Jeon HG, Choo SH, Sung HH, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM (2014) Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma. Eur J Cancer 50:64–69. doi:10.1016/j.ejca.2013.08.018 CrossRefPubMed Jeon HG, Choo SH, Sung HH, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM (2014) Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma. Eur J Cancer 50:64–69. doi:10.​1016/​j.​ejca.​2013.​08.​018 CrossRefPubMed
11.
12.
go back to reference Kato F, Kamishima T, Morita K, Muto NS, Okamoto S, Omatsu T, Oyama N, Terae S, Kanegae K, Nonomura K, Shirato H (2011) Rapid estimation of split renal function in kidney donors using software developed for computed tomographic renal volumetry. Eur J Radiol 79:15–20. doi:10.1016/j.ejrad.2009.11.013 CrossRefPubMed Kato F, Kamishima T, Morita K, Muto NS, Okamoto S, Omatsu T, Oyama N, Terae S, Kanegae K, Nonomura K, Shirato H (2011) Rapid estimation of split renal function in kidney donors using software developed for computed tomographic renal volumetry. Eur J Radiol 79:15–20. doi:10.​1016/​j.​ejrad.​2009.​11.​013 CrossRefPubMed
13.
18.
go back to reference Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS (2012) Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 307:1941–1951. doi:10.1001/jama.2012.3954 CrossRefPubMed Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS (2012) Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 307:1941–1951. doi:10.​1001/​jama.​2012.​3954 CrossRefPubMed
19.
go back to reference Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2009) American joint committee on cancer (AJCC) staging manual, 7th edn. Springer, Philadelphia Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2009) American joint committee on cancer (AJCC) staging manual, 7th edn. Springer, Philadelphia
20.
go back to reference Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663CrossRefPubMed Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663CrossRefPubMed
21.
go back to reference Prassopoulos P, Cavouras D, Gourtsoyiannis N (1993) Pre- and post-nephrectomy kidney enlargement in patients with contralateral renal cancer. Eur Urol 24:58–61PubMed Prassopoulos P, Cavouras D, Gourtsoyiannis N (1993) Pre- and post-nephrectomy kidney enlargement in patients with contralateral renal cancer. Eur Urol 24:58–61PubMed
23.
go back to reference Anderson RG, Bueschen AJ, Lloyd LK, Dubovsky EV, Burns JR (1991) Short-term and long-term changes in renal function after donor nephrectomy. J Urol 145:11–13PubMed Anderson RG, Bueschen AJ, Lloyd LK, Dubovsky EV, Burns JR (1991) Short-term and long-term changes in renal function after donor nephrectomy. J Urol 145:11–13PubMed
24.
go back to reference Azurmendi PJ, Oddo EM, Toledo JE, Martin RS, Ibarra FR, Arrizurieta EE (2013) Sexual hormones modulate compensatory renal growth and function. Medicina (B Aires) 73:513–519 Azurmendi PJ, Oddo EM, Toledo JE, Martin RS, Ibarra FR, Arrizurieta EE (2013) Sexual hormones modulate compensatory renal growth and function. Medicina (B Aires) 73:513–519
Metadata
Title
Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma
Authors
Bong Hee Park
Hyun Hwan Sung
Byong Chang Jeong
Seong II Seo
Seong Soo Jeon
Hyun Moo Lee
Han Yong Choi
Hwang Gyun Jeon
Publication date
01-06-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 6/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1250-y

Other articles of this Issue 6/2016

International Urology and Nephrology 6/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.